Publications by authors named "Bernard A Fox"

100Publications

Multicenter International Society for Immunotherapy of Cancer Study of the Consensus Immunoscore for the Prediction of Survival and Response to Chemotherapy in Stage III Colon Cancer.

J Clin Oncol 2020 Sep 8:JCO1903205. Epub 2020 Sep 8.

INSERM, Laboratory of Integrative Cancer Immunology, Paris, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.03205DOI Listing
September 2020

Future Research Goals in Immunotherapy.

Surg Oncol Clin N Am 2019 07 12;28(3):505-518. Epub 2019 Apr 12.

Laboratory of Molecular and Tumor Immunology, Robert W. Franz Cancer Center, Earle A. Chiles Research Institute, Providence Cancer Institute, Providence Portland Medical Center, Portland, OR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.soc.2019.02.006DOI Listing
July 2019

The Epigenomic Landscape of Pituitary Adenomas Reveals Specific Alterations and Differentiates Among Acromegaly, Cushing's Disease and Endocrine-Inactive Subtypes.

Clin Cancer Res 2018 09 3;24(17):4126-4136. Epub 2018 Jul 3.

Department of Translational Molecular Medicine, John Wayne Cancer Institute at Saint John's Health Center, Providence Health System, Santa Monica, California.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-17-2206DOI Listing
September 2018

Novel frontiers in detecting cancer metastasis.

Clin Exp Metastasis 2018 08 18;35(5-6):403-412. Epub 2018 Jul 18.

Gritstone Oncology, Cambridge, MA, 02139, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10585-018-9918-6DOI Listing
August 2018

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study.

Authors:
Franck Pagès Bernhard Mlecnik Florence Marliot Gabriela Bindea Fang-Shu Ou Carlo Bifulco Alessandro Lugli Inti Zlobec Tilman T Rau Martin D Berger Iris D Nagtegaal Elisa Vink-Börger Arndt Hartmann Carol Geppert Julie Kolwelter Susanne Merkel Robert Grützmann Marc Van den Eynde Anne Jouret-Mourin Alex Kartheuser Daniel Léonard Christophe Remue Julia Y Wang Prashant Bavi Michael H A Roehrl Pamela S Ohashi Linh T Nguyen SeongJun Han Heather L MacGregor Sara Hafezi-Bakhtiari Bradly G Wouters Giuseppe V Masucci Emilia K Andersson Eva Zavadova Michal Vocka Jan Spacek Lubos Petruzelka Bohuslav Konopasek Pavel Dundr Helena Skalova Kristyna Nemejcova Gerardo Botti Fabiana Tatangelo Paolo Delrio Gennaro Ciliberto Michele Maio Luigi Laghi Fabio Grizzi Tessa Fredriksen Bénédicte Buttard Mihaela Angelova Angela Vasaturo Pauline Maby Sarah E Church Helen K Angell Lucie Lafontaine Daniela Bruni Carine El Sissy Nacilla Haicheur Amos Kirilovsky Anne Berger Christine Lagorce Jeffrey P Meyers Christopher Paustian Zipei Feng Carmen Ballesteros-Merino Jeroen Dijkstra Carlijn van de Water Shannon van Lent-van Vliet Nikki Knijn Ana-Maria Mușină Dragos-Viorel Scripcariu Boryana Popivanova Mingli Xu Tomonobu Fujita Shoichi Hazama Nobuaki Suzuki Hiroaki Nagano Kiyotaka Okuno Toshihiko Torigoe Noriyuki Sato Tomohisa Furuhata Ichiro Takemasa Kyogo Itoh Prabhu S Patel Hemangini H Vora Birva Shah Jayendrakumar B Patel Kruti N Rajvik Shashank J Pandya Shilin N Shukla Yili Wang Guanjun Zhang Yutaka Kawakami Francesco M Marincola Paolo A Ascierto Daniel J Sargent Bernard A Fox Jérôme Galon

Lancet 2018 05 10;391(10135):2128-2139. Epub 2018 May 10.

INSERM, Laboratory of Integrative Cancer Immunology, Paris, France; Université Paris Descartes, Sorbonne Paris Cité, Paris, France; Centre de Recherche des Cordeliers, Université Pierre et Marie Curie, Sorbonne Universités, Paris, France. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S0140-6736(18)30789-XDOI Listing
May 2018

Coordinated responses to individual tumor antigens by IgG antibody and CD8+ T cells following cancer vaccination.

J Immunother Cancer 2018 04 5;6(1):27. Epub 2018 Apr 5.

Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Cancer Institute, 2N56 North Pavilion, 4805 NE Glisan St., Portland, OR, 97213, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-018-0331-0DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5885379PMC
April 2018

Relationships matter in oral cancer: will single-stain immunohistochemistry become irrelevant in the age of multispectral imaging?

Oral Surg Oral Med Oral Pathol Oral Radiol 2017 12 28;124(6):517-518. Epub 2017 Sep 28.

Earle A. Chiles Research Institute in the Robert W. Franz Cancer Center at Providence Portland Medical Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oooo.2017.09.010DOI Listing
December 2017

STING expression and response to treatment with STING ligands in premalignant and malignant disease.

PLoS One 2017 14;12(11):e0187532. Epub 2017 Nov 14.

Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR, United States of America.

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0187532PLOS
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5685615PMC
December 2017

Timing of PD-1 Blockade Is Critical to Effective Combination Immunotherapy with Anti-OX40.

Clin Cancer Res 2017 Oct 28;23(20):6165-6177. Epub 2017 Aug 28.

Earle A. Chiles Research Institute, Robert W. Franz Cancer Research Center, Providence Portland Cancer Center, Portland, Oregon.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-2677DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5641261PMC
October 2017

Ubiquitinated Proteins Isolated From Tumor Cells Are Efficient Substrates for Antigen Cross-Presentation.

J Immunother 2017 06;40(5):155-163

*School of Medicine, Southeast University, Nanjing, P.R. China †Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, OR.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0000000000000165DOI Listing
June 2017

Immunoprofiling as a predictor of patient's response to cancer therapy-promises and challenges.

Curr Opin Immunol 2017 Apr 20;45:60-72. Epub 2017 Feb 20.

Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, United States; Department of Molecular Microbiology and Immunology, Oregon Health & Science University, Portland, OR, United States. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.coi.2017.01.005DOI Listing
April 2017

Erratum to 'Cytoreductive surgery for head and neck squamous cell carcinoma in the new age of immunotherapy' [Oral Oncol. 61 (2016) 166-176].

Oral Oncol 2017 03 12;66:e3. Epub 2017 Feb 12.

Earle A. Chiles Research Institute at Providence Cancer Center, 4805 NE Glisan St. Suite 2N35, Portland, OR 97213, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2017.02.001DOI Listing
March 2017

Combinational Immunotherapy with Allo-DRibble Vaccines and Anti-OX40 Co-Stimulation Leads to Generation of Cross-Reactive Effector T Cells and Tumor Regression.

Sci Rep 2016 11 22;6:37558. Epub 2016 Nov 22.

Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, OR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/srep37558DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5118714PMC
November 2016

Cytoreductive surgery for head and neck squamous cell carcinoma in the new age of immunotherapy.

Oral Oncol 2016 10 7;61:166-76. Epub 2016 Sep 7.

Earle A. Chiles Research Institute at Providence Cancer Center, 4805 NE Glisan St. Suite 2N35, Portland, OR 97213, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2016.08.020DOI Listing
October 2016

OX40, PD-1 and CTLA-4 are selectively expressed on tumor-infiltrating T cells in head and neck cancer.

Clin Transl Immunology 2016 Apr 15;5(4):e70. Epub 2016 Apr 15.

AgonOx, Inc., Portland, OR, USA; Earle A Chiles Research Institute in the Providence Cancer Center, Portland, OR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/cti.2016.16DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855266PMC
April 2016

Glimpse into the future: harnessing autophagy to promote anti-tumor immunity with the DRibbles vaccine.

J Immunother Cancer 2016 17;4:25. Epub 2016 May 17.

Earle A. Chiles Research Institute / Providence Portland Cancer Center, 4805 N.E. Glisan St., North Tower, Suite 2N87, Portland, OR 97213 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-016-0130-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4869314PMC
May 2016

Multispectral Imaging of T and B Cells in Murine Spleen and Tumor.

J Immunol 2016 05 18;196(9):3943-50. Epub 2016 Mar 18.

Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, OR 97213; Department of Molecular Microbiology & Immunology, Oregon Health & Science University, Portland, OR 97239; and

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1502635DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4834492PMC
May 2016

Immune Monitoring Technology Primer: protein microarray ('seromics').

J Immunother Cancer 2016 19;4. Epub 2016 Jan 19.

Earle A. Chiles Research Institute, Providence Cancer Center, 4805 NE Glisan Street, Portland, OR 97213 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-016-0106-4DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717589PMC
January 2016

OX40 signaling in head and neck squamous cell carcinoma: Overcoming immunosuppression in the tumor microenvironment.

Oral Oncol 2016 Jan 21;52:1-10. Epub 2015 Nov 21.

Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute at the Providence Cancer Center, 4805 NE Glisan St. Suite 2N35, Portland, OR 97213, United States.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.oraloncology.2015.11.009DOI Listing
January 2016

Developing an Immunotherapy Strategy for the Effective Treatment of Oral, Head and Neck Squamous Cell Carcinoma.

J Oral Maxillofac Surg 2015 Dec;73(12 Suppl):S107-15

Chief, Laboratory of Molecular and Tumor Immunology, Robert W. Franz Cancer Research Center in the Earle A. Chiles Research Institute at Providence Cancer Center, Portland, OR.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.joms.2015.05.026DOI Listing
December 2015

Multispectral imaging of formalin-fixed tissue predicts ability to generate tumor-infiltrating lymphocytes from melanoma.

J Immunother Cancer 2015 20;3:47. Epub 2015 Oct 20.

Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, 4805 NE Glisan St, Portland, OR 97213 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-015-0091-zDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4617712PMC
October 2015

Editorial: Advances in Combination Tumor Immunotherapy.

Front Oncol 2015 22;5:198. Epub 2015 Sep 22.

Providence Portland Medical Center, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute , Portland, OR , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2015.00198DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4585267PMC
October 2015

Immunoprofiling for prognostic assessment of colon cancer: a novel complement to ultrastaging.

J Gastrointest Surg 2015 Jun 26;19(6):999-1006. Epub 2015 Mar 26.

Department of Surgical Oncology, The John Wayne Cancer Institute at Providence Saint John's Health Center, 2200 Santa Monica Blvd., Santa Monica, CA, 90404, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11605-015-2759-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4720974PMC
June 2015

Preamble to the 2015 SITC immunotherapy biomarkers taskforce.

J Immunother Cancer 2015 24;3. Epub 2015 Mar 24.

Sidra Medical and Research Center, Doha, Qatar.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s40425-015-0052-6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4371796PMC
March 2015

Sustained complete response to CTLA-4 blockade in a patient with metastatic, castration-resistant prostate cancer.

Cancer Immunol Res 2014 May 3;2(5):399-403. Epub 2014 Feb 3.

Authors' Affiliations: Department of Pathology, Providence Health System, Portland, Oregon.

View Article

Download full-text PDF

Source
http://cancerimmunolres.aacrjournals.org/cgi/doi/10.1158/232
Publisher Site
http://dx.doi.org/10.1158/2326-6066.CIR-13-0193DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4418943PMC
May 2014

Future of cancer vaccines.

Methods Mol Biol 2014 ;1139:555-64

Laboratory of Clinical and Experimental Tumor Immunology, Department of Surgery, Grosshadern Medical Center, Ludwig-Maximilians-University Munich, Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/978-1-4939-0345-0_40DOI Listing
November 2014

Tumor-specific CD4+ T cells maintain effector and memory tumor-specific CD8+ T cells.

Eur J Immunol 2014 Jan 21;44(1):69-79. Epub 2013 Nov 21.

Laboratory of Molecular and Tumor Immunology, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR, USA; Department of Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, OR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/eji.201343718DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4283993PMC
January 2014

Increased frequency of suppressive regulatory T cells and T cell-mediated antigen loss results in murine melanoma recurrence.

J Immunol 2012 Jul 20;189(2):767-76. Epub 2012 Jun 20.

Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Portland, OR 97213, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.1103822DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3552612PMC
July 2012

Active-specific immunotherapy for non-small cell lung cancer.

J Thorac Dis 2011 Jun;3(2):105-14

Department of Surgery-Campus Grosshadern, Thoracic Surgery Center Munich, Laboratory of Clinical and Experimental Tumor Immunology, Ludwig-Maximilians-University, Munich, Germany;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3978/j.issn.2072-1439.2010.12.06DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3256502PMC
June 2011

Defining the critical hurdles in cancer immunotherapy.

Authors:
Bernard A Fox Dolores J Schendel Lisa H Butterfield Steinar Aamdal James P Allison Paolo Antonio Ascierto Michael B Atkins Jirina Bartunkova Lothar Bergmann Neil Berinstein Cristina C Bonorino Ernest Borden Jonathan L Bramson Cedrik M Britten Xuetao Cao William E Carson Alfred E Chang Dainius Characiejus A Raja Choudhury George Coukos Tanja de Gruijl Robert O Dillman Harry Dolstra Glenn Dranoff Lindy G Durrant James H Finke Jerome Galon Jared A Gollob Cécile Gouttefangeas Fabio Grizzi Michele Guida Leif Håkansson Kristen Hege Ronald B Herberman F Stephen Hodi Axel Hoos Christoph Huber Patrick Hwu Kohzoh Imai Elizabeth M Jaffee Sylvia Janetzki Carl H June Pawel Kalinski Howard L Kaufman Koji Kawakami Yutaka Kawakami Ulrich Keilholtz Samir N Khleif Rolf Kiessling Beatrix Kotlan Guido Kroemer Rejean Lapointe Hyam I Levitsky Michael T Lotze Cristina Maccalli Michele Maio Jens-Peter Marschner Michael J Mastrangelo Giuseppe Masucci Ignacio Melero Cornelius Melief William J Murphy Brad Nelson Andrea Nicolini Michael I Nishimura Kunle Odunsi Pamela S Ohashi Jill O'Donnell-Tormey Lloyd J Old Christian Ottensmeier Michael Papamichail Giorgio Parmiani Graham Pawelec Enrico Proietti Shukui Qin Robert Rees Antoni Ribas Ruggero Ridolfi Gerd Ritter Licia Rivoltini Pedro J Romero Mohamed L Salem Rik J Scheper Barbara Seliger Padmanee Sharma Hiroshi Shiku Harpreet Singh-Jasuja Wenru Song Per Thor Straten Hideaki Tahara Zhigang Tian Sjoerd H van Der Burg Paul von Hoegen Ena Wang Marij Jp Welters Hauke Winter Tara Withington Jedd D Wolchok Weihua Xiao Laurence Zitvogel Heinz Zwierzina Francesco M Marincola Thomas F Gajewski Jon M Wigginton Mary L Disis

J Transl Med 2011 Dec 14;9:214. Epub 2011 Dec 14.

Earle A, Chiles Research Institute, Robert W, Franz Research Center, Providence Cancer Center, Providence Portland Medical Center, Portland, OR, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1479-5876-9-214DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3338100PMC
December 2011

Tumor-derived autophagosome vaccine: mechanism of cross-presentation and therapeutic efficacy.

Clin Cancer Res 2011 Nov 8;17(22):7047-57. Epub 2011 Nov 8.

Laboratory of Cancer Immunobiology, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Portland Medical Center, Portland, Oregon 97213, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-0951DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3495614PMC
November 2011

Multiple vaccinations: friend or foe.

Cancer J 2011 Sep-Oct;17(5):379-96

Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Portland Medical Center, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PPO.0b013e3182346320DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3614402PMC
March 2012

Tumor-derived autophagosome vaccine: induction of cross-protective immune responses against short-lived proteins through a p62-dependent mechanism.

Clin Cancer Res 2011 Oct 2;17(20):6467-81. Epub 2011 Aug 2.

Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Providence Portland Medical Center, Portland, Oregon, USA.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/content/17/22/7047.ful
Web Search
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-11-0812DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298078PMC
October 2011

Immunotherapy of cancer: key findings and commentary on the third Tegernsee conference.

Oncologist 2010 8;15(1):112-8. Epub 2010 Jan 8.

F.A.C.S., Laboratory of Clinical and Experimental Tumor Immunology, Department of Surgery, Grosshadern Medical Center, Ludwig-Maximilians-University Munich, Marchioninistrasse 15, 81377 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2009-0213DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3227889PMC
May 2010

Partial CD4 depletion reduces regulatory T cells induced by multiple vaccinations and restores therapeutic efficacy.

Clin Cancer Res 2009 Nov 10;15(22):6881-90. Epub 2009 Nov 10.

Laboratory of Molecular and Tumor Immunology, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Cancer Center, Oregon Health and Science University, Portland, Oregon, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-09-1113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2784281PMC
November 2009

Depletion of tumor-induced Treg prior to reconstitution rescues enhanced priming of tumor-specific, therapeutic effector T cells in lymphopenic hosts.

Eur J Immunol 2009 Nov;39(11):3121-33

Laboratory of Molecular and Tumor Immunology, Earle A. Chiles Research Institute, Robert W. Franz Cancer Center, Providence Portland Medical Center, Portland, OR 97213, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/eji.200939453
Publisher Site
http://dx.doi.org/10.1002/eji.200939453DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2850261PMC
November 2009

Disruption of TGF-beta signaling prevents the generation of tumor-sensitized regulatory T cells and facilitates therapeutic antitumor immunity.

J Immunol 2009 Sep 19;183(6):3682-9. Epub 2009 Aug 19.

Laboratory of Molecular and Tumor Immunology, Robert W Franz Cancer Research Center, Earle A Chiles Research Institute, Providence Cancer Center and Providence Portland Medical Center, Portland, OR 97213, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4049/jimmunol.0900560DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2850273PMC
September 2009

Cross-presentation of tumor associated antigens through tumor-derived autophagosomes.

Autophagy 2009 May 6;5(4):576-7. Epub 2009 May 6.

Laboratory of Cancer Immunobiology, Providence Portland Medical Center, 4805 N.E. Glisan Street, Portland, OR 97213, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3128909PMC
http://dx.doi.org/10.4161/auto.5.4.8366DOI Listing
May 2009

Increased susceptibility to immune destruction of B16BL6 tumor cells engineered to express a novel pro-Smac fusion protein.

J Immunother 2008 Jan;31(1):43-51

Laboratory of Molecular and Tumor Immunology, Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Portland Medical Center, OR 97213, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0b013e318158fd16DOI Listing
January 2008

Current immunotherapeutic strategies in lung cancer.

Surg Oncol Clin N Am 2007 Oct;16(4):901-18, x

Department of Surgery, Laboratory of Clinical and Experimental Tumor Immunology, Grosshadern Medical Center, Ludwig-Maximilians-University Munich, Marchioninistrasse 15, 81377 Munich, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.soc.2007.07.004DOI Listing
October 2007

Induction of circulating tumor-reactive CD8+ T cells after vaccination of melanoma patients with the gp100 209-2M peptide.

J Immunother 2007 Jul-Aug;30(5):533-43

Robert W. Franz Cancer Research Center, Earle A. Chiles Research Institute, Providence Portland Medical Center, 4805 NE Glisan Street, Portland, OR 97213, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/CJI.0b013e3180335b5eDOI Listing
August 2007

Tumor-specific T cells signal tumor destruction via the lymphotoxin beta receptor.

J Transl Med 2007 Mar 13;5:14. Epub 2007 Mar 13.

Laboratory of Cancer Immunobiology, Robert W, Franz Cancer Research Center, Earle A, Chiles Research Institute, Providence Portland Medical Center, Portland, Oregon, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1479-5876-5-14DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1838896PMC
March 2007

Immunotherapy of lung cancer: an update.

Onkologie 2006 Feb;29(1-2):33-8

Chirurgische Klinik und Poliklinik, Abteilung für Transfusionsmedizin und Hämostaseologie, Klinikum Grosshadern, Ludwig-Maximilians-Universität München, München, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000090341DOI Listing
February 2006

[Mechanism of augmented anti-tumor immunity in reconstituted lymphopenic mice immunized with melanoma vaccine].

Zhonghua Zhong Liu Za Zhi 2005 Dec;27(12):708-12

The Key Laboratory of Biomedical Information Engineering of Ministry of Education, Institute for Cancer Research, School of Life Science & Technology, Xi'an Jiaotong University, Xi'an, 710061, China.

View Article

Download full-text PDF

Source
December 2005